Dominik Wolf

Dominik Wolf

Medizinische Universität Innsbruck

H-index: 57

Europe-Austria

About Dominik Wolf

Dominik Wolf, With an exceptional h-index of 57 and a recent h-index of 45 (since 2020), a distinguished researcher at Medizinische Universität Innsbruck, specializes in the field of Cancer, Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease

Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders

Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report

Relapse protection following early cytomegalovirus reactivation after hematopoietic stem cell transplantation is limited to HLA-c killer cell immunoglobulin-like receptor …

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events

The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic

Austrian recommendations for the management of essential thrombocythemia

Dominik Wolf Information

University

Position

___

Citations(all)

14529

Citations(since 2020)

7386

Cited By

9540

hIndex(all)

57

hIndex(since 2020)

45

i10Index(all)

145

i10Index(since 2020)

114

Email

University Profile Page

Medizinische Universität Innsbruck

Google Scholar

View Google Scholar Profile

Dominik Wolf Skills & Research Interests

Cancer

Immunology

Top articles of Dominik Wolf

Title

Journal

Author(s)

Publication Date

Improvement in colorectal cancer outcomes over time is limited to patients with left-sided disease

Journal of Cancer Research and Clinical Oncology

Holger Rumpold

Monika Hackl

Andreas Petzer

Dominik Wolf

2022/11/1

Functional precision medicine provides clinical benefit in advanced aggressive hematologic cancers and identifies exceptional responders

Cancer discovery

Christoph Kornauth

Tea Pemovska

Gregory I Vladimer

Günther Bayer

Michael Bergmann

...

2022/2/1

Sustained Complete Remission in Multi-Relapsed Primary CNS Lymphoma Treated with Ibrutinib Monotherapy: A Case Report

Case Reports in Oncology

Anna Mair

Armin Muigg

Günther Stockhammer

Stephanie Mangesius

Dominik Wolf

...

2022/1/6

Relapse protection following early cytomegalovirus reactivation after hematopoietic stem cell transplantation is limited to HLA-c killer cell immunoglobulin-like receptor …

Transplantation and Cellular Therapy

Alexander Nikoloudis

Helga Wagner

Sigrid Machherndl-Spandl

Veronika Buxhofer-Ausch

Irene Strassl

...

2021/8/1

Clonal dynamics in a composite chronic lymphocytic leukemia and hairy cell leukemia‐variant

Genes, Chromosomes and Cancer

Maurus Locher

Emina Jukic

Jan‐Paul Bohn

Gerold Untergasser

Michael Steurer

...

2021/4

Increased levels of NETosis in myeloproliferative neoplasms are not linked to thrombotic events

Blood Advances

Stefan Schmidt

Dimitri Daniliants

Elisabeth Hiller

Eberhard Gunsilius

Dominik Wolf

...

2021/9/28

The cancer patient’s perspective of COVID‐19‐induced distress—A cross‐sectional study and a longitudinal comparison of HRQOL assessed before and during the pandemic

Cancer medicine

Karin A Koinig

Christoph Arnold

Jens Lehmann

Johannes Giesinger

Stefan Köck

...

2021/6

Austrian recommendations for the management of essential thrombocythemia

Wiener klinische Wochenschrift

Veronika Buxhofer-Ausch

Sonja Heibl

Thamer Sliwa

Christine Beham-Schmid

Dominik Wolf

...

2021/1

Pacritinib protects dendritic cells more efficiently than ruxolitinib

Experimental hematology

Annkristin Heine

Anna Maria Wolf

Sebastian Schlaweck

Solveig Nora Daecke

Peter Brossart

...

2021/8/1

Symmetric bilateral liposarcoma in an interventional cardiologist

The Lancet Oncology

Eberhard Gunsilius

Reto Bale

Christian Uprimny

Dominik Wolf

2021/4/1

Clonal hematopoiesis in patients with Covid‐19 is stable and not linked to an aggravated clinical course

American Journal of Hematology

Verena Petzer

Simon Schwendinger

David Haschka

Verena Vogi

Piotr Tymoszuk

...

2021/9

Environmental aspects in myelodysplastic syndrome

Verena Petzer

Igor Theurl

Günter Weiss

Dominik Wolf

2021/5/14

High indoleamine-2, 3-dioxygenase 1 (IDO) activity is linked to primary resistance to immunotherapy in non-small cell lung cancer (NSCLC)

Translational Lung Cancer Research

Florian Kocher

Arno Amann

Kai Zimmer

Simon Geisler

Dietmar Fuchs

...

2021/1

Fecal microbiota transfer for refractory intestinal graft‐versus‐host disease—experience from two German tertiary centers

European journal of haematology

Felix Goeser

Barbara Sifft

Christoph Stein‐Thoeringer

Fedja Farowski

Christian P Strassburg

...

2021/8

Rheumatologic diseases impact the risk of progression of MGUS to overt multiple myeloma

Blood Advances

Normann Steiner

Georg Göbel

Daniela Michaeler

Anna-Luise Platz

Wolfgang Prokop

...

2021/3/23

Deregulated glutamate to pro-collagen conversion is associated with adverse outcome in lung cancer and may be targeted by renin-angiotensin-aldosterone system (RAS) inhibition

Lung Cancer

Florian Kocher

Piotr Tymoszuk

Arno Amann

Susanne Sprung

Stefan Salcher

...

2021/9/1

Helios-expressing CD8+ T cells are decreased in patients with systemic lupus erythematosus

Lupus

Tobias AW Holderried

Mareike Kruse

Michael Serries

Peter Brossart

Dominik Wolf

...

2021/5

Rare lung cancers—Primary pulmonary leiomyosarcoma: A case report

memo-Magazine of European Medical Oncology

Laurenz Nagl

Andreas Seeber

Gerlig Widmann

Katja Schmitz

Herbert Maier

...

2021/12

Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia

European Journal of Haematology

Veronika Buxhofer‐Ausch

Dominik Wolf

Siegfried Sormann

Ernst Forjan

Wolfgang Schimetta

...

2021/1

Discontinuation versus continuation of renin-angiotensin-system inhibitors in COVID-19 (ACEI-COVID): a prospective, parallel group, randomised, controlled, open-label trial

The Lancet Respiratory Medicine

Axel Bauer

Michael Schreinlechner

Nikolay Sappler

Theresa Dolejsi

Herbert Tilg

...

2021/8/1

See List of Professors in Dominik Wolf University(Medizinische Universität Innsbruck)